Skip to main content
TipRanks
Go Ultimate75% OFF

SK Biopharmaceuticals Co., Ltd. (326030) Cash flow

SK Biopharmaceuticals Co., Ltd. Cash Flow

KR:326030's free cash flow for Q2 2026 was ₩77.36B. For the 2026 fiscal year, KR:326030's free cash flow was decreased by ₩-790.56M and operating cash flow was ₩78.15B. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
₩ 180.53B₩ 94.90B₩ -94.20B₩ -159.92B₩ -92.87B
₩ -35.42B₩ -10.94B₩ 225.27B₩ -95.71B₩ 258.97B
₩ -156.68B₩ -4.50B₩ 6.62B₩ 134.91B₩ -4.65B
₩ 307.77B₩ 322.81B₩ 239.70B₩ 104.06B₩ 225.92B
₩ 173.64B₩ 81.48B₩ -97.45B₩ -165.88B₩ -98.86B

Currency in KRW

SK Biopharmaceuticals Co., Ltd. Cash Flow

-400B-200B0200B400B600B201720182019202020212022202320242025OperatingInvestingFinancing